111 related articles for article (PubMed ID: 21293259)
1. Comparative analysis of detecting monocytic cells and their aberrancy.
Dunphy CH
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):336-40. PubMed ID: 21293259
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of enzyme cytochemistry and flow cytometric immunophenotyping to the evaluation of acute myeloid leukemias with a monocytic component and of flow cytometric immunophenotyping to the evaluation of absolute monocytoses.
Dunphy CH; Orton SO; Mantell J
Am J Clin Pathol; 2004 Dec; 122(6):865-74. PubMed ID: 15539379
[TBL] [Abstract][Full Text] [Related]
3. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.
Rollins-Raval MA; Roth CG
Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of monocytic leukemias: usefulness of CD14 and Kruppel-like factor 4, a novel monocyte marker.
Klco JM; Kulkarni S; Kreisel FH; Nguyen TD; Hassan A; Frater JL
Am J Clin Pathol; 2011 May; 135(5):720-30. PubMed ID: 21502426
[TBL] [Abstract][Full Text] [Related]
5. CD163: a specific immunohistochemical marker for acute myeloid leukemia with monocytic differentiation.
Garcia C; Gardner D; Reichard KK
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):417-21. PubMed ID: 18542032
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression.
Sojitra P; Gandhi P; Fitting P; Kini AR; Alkan S; Velankar MM; Venkataraman G
Am J Clin Pathol; 2013 Nov; 140(5):686-92. PubMed ID: 24124148
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
8. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.
Ko YH; Kim SH; Park K; Ree HJ
J Korean Med Sci; 2002 Dec; 17(6):833-9. PubMed ID: 12483012
[TBL] [Abstract][Full Text] [Related]
10. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
[TBL] [Abstract][Full Text] [Related]
12. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
Gibson SE; Dong HY; Advani AS; Hsi ED
Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
[TBL] [Abstract][Full Text] [Related]
13. Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.
Leong CF; Raudhawati O; Cheong SK; Sivagengei K; Noor Hamidah H
Pathology; 2003 Oct; 35(5):422-7. PubMed ID: 14555387
[TBL] [Abstract][Full Text] [Related]
14. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
15. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
Leuk Lymphoma; 2011 Jan; 52(1):92-100. PubMed ID: 21219126
[TBL] [Abstract][Full Text] [Related]
16. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
18. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
[TBL] [Abstract][Full Text] [Related]
19. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610
[TBL] [Abstract][Full Text] [Related]
20. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
